FN2 Earnings Intelligence
Guardant Health, Inc. income statement (quarterly)
Guardant Health, Inc. (GH) Income Statement (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 | 12/30/2026 est. | 12/31/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $629.1 | $580 | $989.3 | $1,053.5 | $1,026.8 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $232.1 | $265.2 | $301.7 | $335 | $361 | $369.3 | $358.9 |
| % Growth | - | - | - | - | - | - | - |
| Gross Profit | $150.9 | $171.6 | $196.7 | $219 | $236.2 | - | - |
| % Margin | 65.0% | 64.7% | 65.2% | 65.4% | 65.4% | - | - |
| EBITDA | -$96.8 | -$90 | -$111.9 | -$119.8 | -$122.9 | - | - |
| % Margin | -41.7% | -33.9% | -37.1% | -35.8% | -34.0% | - | - |
| Net Income | -$99.9 | -$92.7 | -$112.1 | -$120.1 | -$124.4 | - | - |
| % Margin | -43.0% | -35.0% | -37.2% | -35.9% | -34.5% | - | - |
| Diluted EPS | -$0.80 | -$0.74 | -$0.85 | -$0.90 | -$0.93 | -$0.73 | -$0.63 |
| % Growth | - | - | - | - | - | - | - |
| Operating Cash Flow | - | - | -$65.6 | - | - | - | - |
| CapEx | - | - | $5.6 | - | - | - | - |
| Free Cash Flow | - | - | -$71.2 | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 | 12/30/2026 est. | 12/31/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $232.1 | $265.2 | $301.7 | $335 | $361 | $369.3 | $358.9 |
| Gross Profit | $150.9 | $171.6 | $196.7 | $219 | $236.2 | - | - |
| EBITDA | -$96.8 | -$90 | -$111.9 | -$119.8 | -$122.9 | - | - |
| Net Income | -$99.9 | -$92.7 | -$112.1 | -$120.1 | -$124.4 | - | - |
| Diluted EPS | -$0.80 | -$0.74 | -$0.85 | -$0.90 | -$0.93 | -$0.73 | -$0.63 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $629.1 | $580 | $989.3 | $1,053.5 | $1,026.8 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $1,115.5 | $1,114.6 | $1,503.5 | $1,502.9 | $1,502.4 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | - | -$65.6 | - | - |
| Capital Expenditure | - | - | $5.6 | - | - |
| Free Cash Flow | - | - | -$71.2 | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 | 9/30/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 65.0% | 64.7% | 65.2% | 65.4% | 65.4% |
| EBITDA Margin | -41.7% | -33.9% | -37.1% | -35.8% | -34.0% |
| Net Margin | -43.0% | -35.0% | -37.2% | -35.9% | -34.5% |
| FCF Margin | - | - | -23.6% | - | - |
| Diluted EPS Growth | - | - | - | - | - |
Get the GH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.